{"schema_version":"secwatch.filing_event.v1","accession":"0001818331-21-000002","form_type":"8-K","ticker":"WGS","cik":"0001818331","company_name":"GeneDx Holdings Corp.","filed_at":"2021-10-14T23:59:59+00:00","discovered_at":"2026-05-14T18:04:14.304267+00:00","generated_at":"2026-06-28T20:54:32.165600+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"high","headline":"Sema4 President and COO James Coffin to take 90-day medical leave; CFO and CBO to assume duties","bullets":["James Coffin, President and COO, expects 90-day disability leave starting October 2021.","CFO Isaac Ro and Chief Business Officer Kareem Saad will perform Coffin's functions during leave.","Company does not anticipate adverse impact on financial performance or corporate objectives."],"urls":{"canonical":"https://secwatch.observer/filing/0001818331-21-000002","json":"https://secwatch.observer/filing/0001818331-21-000002.json","markdown":"https://secwatch.observer/filing/0001818331-21-000002.md","text":"https://secwatch.observer/filing/0001818331-21-000002.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818331/000181833121000002/0001818331-21-000002-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818331/000181833121000002/smfr-20211008.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T20:54:32.165600+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"111ed9babf","claim":"James Coffin changed role as President and Chief Operating Officer at GeneDx Holdings Corp..","evidence_excerpt":"James Coffin, Ph.D. the Company’s Treasurer from January 2021 to March 2021, and President and Chief Operating Officer since 2017, expects to be on short-term disability leave for medical reasons for approximately 90 days, commencing sometime in October 2021 (the “Leave”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818331/000181833121000002/0001818331-21-000002-index.htm","confidence":0.9,"family_label":"Executive change","details":[{"label":"Action","value":"Taking 90-day medical leave"},{"label":"Role","value":"President and Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}